Bristol Myers beats quarterly revenue estimates on strong Opdivo sales

Bristol Myers Squibb beat Wall Street estimates for third-quarter revenue on Thursday, as strong growth of its cancer immunotherapy and blood thinner Eliquis helped the drugmaker overcome a hit from g... ...